[2]
Das G,Tschida V,Gray R,Dhurandhar R,Lester R,McGrew F,Askenazi J,Kaplan K,Emanuele M,Turlapaty P, Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. Journal of clinical pharmacology. 1988 Aug;
[PubMed PMID: 2905710]
[3]
Gray RJ,Bateman TM,Czer LS,Conklin CM,Matloff JM, Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. Journal of the American College of Cardiology. 1985 Jun
[PubMed PMID: 2860148]
[4]
Garnock-Jones KP, Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension. Drugs. 2012 Jan 1
[PubMed PMID: 22191799]
[5]
Gassanov N,Er F, [The Role of Ultrarapid Acting Betablocker Esmolol and Landiolol in Critically Ill Patients]. Deutsche medizinische Wochenschrift (1946). 2019 Sep
[PubMed PMID: 31514219]
[6]
Sung RJ,Blanski L,Kirshenbaum J,MacCosbe P,Turlapaty P,Laddu AR, Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia. Journal of clinical pharmacology. 1986 Mar
[PubMed PMID: 2870082]
[7]
Aydogan MS,Yücel A,Begec Z,Colak YZ,Durmus M, The hemodynamic effects of dexmedetomidine and esmolol in electroconvulsive therapy: a retrospective comparison. The journal of ECT. 2013 Dec;
[PubMed PMID: 23774056]
Level 2 (mid-level) evidence
[8]
Patrick C,Crowe RP,Ward B,Mohammed A,Keene KR,Dickson R, Feasibility of prehospital esmolol for refractory ventricular fibrillation. Journal of the American College of Emergency Physicians open. 2022 Apr
[PubMed PMID: 35425942]
Level 2 (mid-level) evidence
[9]
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019 Jul 9:140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28
[PubMed PMID: 30686041]
Level 1 (high-level) evidence
[10]
Three generations of β-blockers: history, class differences and clinical applicability., do Vale GT,Ceron CS,Gonzaga NA,Simplicio JA,Padovan JC,, Current hypertension reviews, 2018 Sep 17
[PubMed PMID: 30227820]
[11]
Agrios J,Kaladaridou A,Bramos D,Skaltsiotes E,Pamboucas C,Papadopoulou E,Toumanidis S,Moulopoulos S, The acute effects of esmolol on left ventricular hemodynamic, rotational mechanics and strain in intact and infracted myocardium: An experimental study. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese. 2021 Jul-Aug
[PubMed PMID: 32800920]
[12]
Wiest DB,Haney JS, Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clinical pharmacokinetics. 2012 Jun 1
[PubMed PMID: 22515557]
[14]
Covinsky JO, Esmolol: a novel cardioselective, titratable, intravenous beta-blocker with ultrashort half-life. Drug intelligence & clinical pharmacy. 1987 Apr
[PubMed PMID: 2882993]
[15]
Poveda-Jaramillo R,Monaco F,Zangrillo A,Landoni G, Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients. Journal of cardiothoracic and vascular anesthesia. 2018 Jun;
[PubMed PMID: 29398384]
[16]
Wiest D, Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clinical pharmacokinetics. 1995 Mar;
[PubMed PMID: 7758250]
[17]
Rhoney D,Peacock WF, Intravenous therapy for hypertensive emergencies, part 2. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2009 Aug 15;
[PubMed PMID: 19667001]
[19]
Krenz JR,O'Brien ME,Lee J,Hayes BD, Evaluation of esmolol for heart rate control in patients with acute aortic dissection. The American journal of emergency medicine. 2021 Jun
[PubMed PMID: 32354528]
[20]
Kloner RA,Kirshenbaum J,Lange R,Antman EM,Braunwald E, Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. The American journal of cardiology. 1985 Oct 23
[PubMed PMID: 2864848]
[21]
Howie MB,Hiestand DC,Zvara DA,Kim PY,McSweeney TD,Coffman JA, Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation. Anesthesia and analgesia. 1992 Nov;
[PubMed PMID: 1358003]
[22]
Buchi KN,Rollins DE,Tolman KG,Achari R,Drissel D,Hulse JD, Pharmacokinetics of esmolol in hepatic disease. Journal of clinical pharmacology. 1987 Nov
[PubMed PMID: 3323260]
[23]
Flaherty JF,Wong B,La Follette G,Warnock DG,Hulse JD,Gambertoglio JG, Pharmacokinetics of esmolol and ASL-8123 in renal failure. Clinical pharmacology and therapeutics. 1989 Mar
[PubMed PMID: 2563962]
[24]
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA, ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European heart journal. 2018 Sep 7:39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. Epub
[PubMed PMID: 30165544]
[25]
Ostman PL,Chestnut DH,Robillard JE,Weiner CP,Hdez MJ, Transplacental passage and hemodynamic effects of esmolol in the gravid ewe. Anesthesiology. 1988 Nov;
[PubMed PMID: 2903702]
[26]
Yu SK,Tait G,Karkouti K,Wijeysundera D,McCluskey S,Beattie WS, The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials. Anesthesia and analgesia. 2011 Feb
[PubMed PMID: 21127279]
Level 1 (high-level) evidence
[27]
Byrd RC,Sung RJ,Marks J,Parmley WW, Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias. Journal of the American College of Cardiology. 1984 Feb;
[PubMed PMID: 6141193]
[28]
Beta Adrenergic Blocking Agents LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012
[PubMed PMID: 31643457]
[29]
Cork RC,Kramer TH,Dreischmeier B,Behr S,DiNardo JA, The effect of esmolol given during cardiopulmonary bypass. Anesthesia and analgesia. 1995 Jan
[PubMed PMID: 7802296]
[30]
Pham D,Addison D,Kayani W,Misra A,Jneid H,Resar J,Lakkis N,Alam M, Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis. Emergency medicine journal : EMJ. 2018 Sep
[PubMed PMID: 29921621]
Level 1 (high-level) evidence
[31]
Askenazi J,MacCosbe PE,Hoff J,Turlapaty P,Hua TA,Laddu A, Hemodynamic effects of esmolol, an ultrashort-acting beta blocker. Journal of clinical pharmacology. 1987 Aug
[PubMed PMID: 2888793]
[32]
Lowenthal DT,Porter RS,Achari R,Turlapaty P,Laddu AR,Matier WL, Esmolol-digoxin drug interaction. Journal of clinical pharmacology. 1987 Aug;
[PubMed PMID: 2888792]
[33]
Kim KS,Kim KH,Shin WJ,Yoo HK, Neuromuscular interactions between mivacurium and esmolol in rabbits. Anaesthesia. 1998 Feb;
[PubMed PMID: 9534636]
[34]
Bensky KP,Donahue-Spencer L,Hertz GE,Anderson MT,James R, The dose-related effects of bolus esmolol on heart rate and blood pressure following laryngoscopy and intubation. AANA journal. 2000 Oct
[PubMed PMID: 11759128]
[35]
Sheppard D,DiStefano S,Byrd RC,Eschenbacher WL,Bell V,Steck J,Laddu A, Effects of esmolol on airway function in patients with asthma. Journal of clinical pharmacology. 1986 Mar;
[PubMed PMID: 2870080]
[36]
Tao Y,Jingyi W,Xiaogan J,Weihua L,Xiaoju J, [Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock]. Zhonghua wei zhong bing ji jiu yi xue. 2015 Nov
[PubMed PMID: 27132454]
[37]
Barbier GH,Shettigar UR,Appunn DO, Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. International journal of clinical pharmacology and therapeutics. 1995 Apr
[PubMed PMID: 7620691]
[38]
Litman RS,Zerngast BA, Cardiac arrest after esmolol administration: a review of acute beta-blocker toxicity. The Journal of the American Osteopathic Association. 1996 Oct
[PubMed PMID: 8936932]
[39]
Kapitein B,Biesmans RCG,van der Sijs H,de Wildt SN, Propylene Glycol-Related Delirium After Esmolol Infusion. The Annals of pharmacotherapy. 2014 Jul;
[PubMed PMID: 24687543]
[41]
Rotella JA,Greene SL,Koutsogiannis Z,Graudins A,Hung Leang Y,Kuan K,Baxter H,Bourke E,Wong A, Treatment for beta-blocker poisoning: a systematic review. Clinical toxicology (Philadelphia, Pa.). 2020 Oct;
[PubMed PMID: 32310006]
Level 1 (high-level) evidence
[42]
Kirchhof P, Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines. Heart (British Cardiac Society). 2017 May
[PubMed PMID: 28077464]